These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 27504181)

  • 1. Assessing the sensitivity and representativeness of the Belgian Sentinel Network of Laboratories using test reimbursement data.
    Berger N; Muyldermans G; Dupont Y; Quoilin S
    Arch Public Health; 2016; 74():29. PubMed ID: 27504181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence estimation from sentinel surveillance data; a simulation study and application to data from the Belgian laboratory sentinel surveillance.
    Braeye T; Quoilin S; Hens N
    BMC Public Health; 2019 Jul; 19(1):982. PubMed ID: 31337363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bigger and Better? Representativeness of the Influenza A Surveillance Using One Consolidated Clinical Microbiology Laboratory Data Set as Compared to the Belgian Sentinel Network of Laboratories.
    Van den Wijngaert S; Bossuyt N; Ferns B; Busson L; Serrano G; Wautier M; Thomas I; Byott M; Dupont Y; Nastouli E; Hallin M; Kozlakidis Z; Vandenberg O
    Front Public Health; 2019; 7():150. PubMed ID: 31275914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of sentinel node identification is maintained with the addition of local lidocaine and subareolar radioactive colloid injection.
    Stearns V; Blackford A; Kessler J; Sbaity E; Habibi M; Khouri N; Lee CS; May E; Jeter S; Sahebi C; Shehata C; Tarpinian K; Jacobs L; Eisner D
    Breast Cancer Res Treat; 2015 Apr; 150(3):589-95. PubMed ID: 25788225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Provincial representativeness assessment of China Non-communicable and Chronic Disease Risk Factor Surveillance System in 2013].
    Zhao ZP; Wang LM; Li YC; Jiang Y; Zhang M; Huang ZJ; Zhang X; Li C; Zhou MG
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Feb; 52(2):165-169. PubMed ID: 29429271
    [No Abstract]   [Full Text] [Related]  

  • 6. Distribution of HCV genotypes in Belgium from 2008 to 2015.
    Bouacida L; Suin V; Hutse V; Boudewijns M; Cartuyvels R; Debaisieux L; De Laere E; Hallin M; Hougardy N; Lagrou K; Oris E; Padalko E; Reynders M; Roussel G; Senterre JM; Stalpaert M; Ursi D; Vael C; Vaira D; Van Acker J; Verstrepen W; Van Gucht S; Kabamba B; Quoilin S; Muyldermans G
    PLoS One; 2018; 13(12):e0207584. PubMed ID: 30517127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological situation of Lyme borreliosis in Belgium, 2003 to 2012.
    Bleyenheuft C; Lernout T; Berger N; Rebolledo J; Leroy M; Robert A; Quoilin S
    Arch Public Health; 2015; 73(1):33. PubMed ID: 26146553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of gonococcal and chlamydial infections and coverage of two laboratory surveillance networks, France, 2012.
    La Ruche G; Le Strat Y; Fromage M; Berçot B; Goubard A; de Barbeyrac B; Sednaoui P; Cambau E; Lot F
    Euro Surveill; 2015 Aug; 20(32):6-15. PubMed ID: 26290487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The profile of newborn screening coverage in China.
    Cao Y; Yuan P; Wang YP; Mao M; Zhu J
    J Med Screen; 2009; 16(4):163-6. PubMed ID: 20054088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.
    Litzroth A; Suin V; Wyndham-Thomas C; Quoilin S; Muyldermans G; Vanwolleghem T; Kabamba-Mukadi B; Verburgh V; Jacques M; Van Gucht S; Hutse V
    BMC Public Health; 2019 Jan; 19(1):39. PubMed ID: 30621662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of methods for measuring coverage and representativeness of an early-warning disease surveillance system.
    Ely ER; Nicholson RE; Snow LC; Strugnell BW; Williamson SM; Milnes AS; Watson EN; Hoinville LJ
    Vet Rec; 2012 Oct; 171(17):423. PubMed ID: 23015726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness.
    Runesson B; Gasparini A; Qureshi AR; Norin O; Evans M; Barany P; Wettermark B; Elinder CG; Carrero JJ
    Clin Kidney J; 2016 Feb; 9(1):119-27. PubMed ID: 26798472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of the Australian Rotavirus Surveillance Program.
    Roberts-Witteveen AR; Patel MS; Roche PW
    Commun Dis Intell Q Rep; 2008 Sep; 32(3):326-32. PubMed ID: 19062768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Belgian rare diseases plan in clinical pathology: identification of key biochemical diagnostic tests and establishment of reference laboratories and financing conditions.
    Vandevelde NM; Vermeersch P; Devreese KMJ; Vincent MF; Gulbis B; Eyskens F; Boemer F; Gothot A; Van Hoof VO; Bonroy C; Stepman H; Martens GA; Bossuyt X; Roosens L; Smet J; Laeremans H; Weets I; Minon JM; Vernelen K; Coucke W;
    Orphanet J Rare Dis; 2021 Feb; 16(1):89. PubMed ID: 33596965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza epidemiology, vaccine coverage and vaccine effectiveness in sentinel Australian hospitals in 2012: the Influenza Complications Alert Network (FluCAN).
    Cheng AC; Brown S; Waterer G; Holmes M; Senenayake S; Friedman ND; Hewagama S; Simpson G; Wark P; Upham J; Korman T; Dwyer D; Wood-Baker R; Irving L; Bowler S; Kotsimbos T; Kelly P
    Commun Dis Intell Q Rep; 2013 Sep; 37(3):E246-52. PubMed ID: 24890961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza epidemiology, vaccine coverage and vaccine effectiveness in sentinel Australian hospitals in 2013: the Influenza Complications Alert Network.
    Cheng AC; Dwyer DE; Holmes M; Irving LB; Brown SG; Waterer GW; Korman TM; Hunter C; Hewagama S; Friedman ND; Wark PA; Simpson G; Upham JW; Bowler SD; Senenayake SN; Kotsimbos TC; Kelly PM
    Commun Dis Intell Q Rep; 2014 Jun; 38(2):E143-9. PubMed ID: 25222208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strengthening public health systems: assessing the attributes of the NSW influenza surveillance system.
    Dawson G; Gilmour R; Tobin S; Travaglia J
    Public Health Res Pract; 2016 Apr; 26(2):. PubMed ID: 27734064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of the Zambia influenza sentinel surveillance system, 2011-2017.
    Simusika P; Tempia S; Chentulo E; Polansky L; Mazaba ML; Ndumba I; Mbewe QK; Monze M
    BMC Health Serv Res; 2020 Jan; 20(1):35. PubMed ID: 31931793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sentinel network of microbiological laboratories as a tool for surveillance of infectious diseases in Belgium.
    Walckiers D; Stroobant A; Yourassowsky E; Lion J; Cornelis R
    Epidemiol Infect; 1991 Apr; 106(2):297-303. PubMed ID: 2019299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Representativeness of the surveillance, epidemiology, and end results program data: recent trends in cancer mortality rates.
    Frey CM; McMillen MM; Cowan CD; Horm JW; Kessler LG
    J Natl Cancer Inst; 1992 Jun; 84(11):872-7. PubMed ID: 1593655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.